In Italy the lack of Vitamin D is particularly frequent. The main factors that can influence the deficiency of this vitamin are skin pigmentation, seasonality, the application of sunscreens, obesity and some drugs. 

Especially the elderly are at greater risk for this condition, particularly in winter. However, Vitamin D deficiency in our country is not limited to them, but has also been widely described in adults, adolescents and children.

In children, vitamin D deficiency can cause rickets, a typical developmental disease characterized by bone deformations with consequent disability. In adults and the elderly, hypovitaminosis D can cause osteomalacia and favor the onset of osteoporosis.

Vitamin D is a fat-soluble vitamin produced by the effect of type B ultraviolet rays on the skin. Maximum production is reached after 10-15 minutes of sun exposure in summer, while excessive exposure determines the formation of inactive photoproducts.

Although its existence had already been theorized at the beginning of the XXth century, the chemical structure of the new Vitamin remained unknown until ‘30 of the XXth century. It was determined by Adolf Otto Reinhold Windaus, who received the Nobel Prize for Chemistry in 1928 for his discovery.

The dosage of circulating 25 OH vitamin D (25OHD) is the unanimously recognized parameter that is a reliable indicator of vitamin D status.

According to the most modern scientific indications, the entire segment of the population considered "at risk" should be screened.

Brand Active Ingredient  ATC Pack Reimbuersement Status
BALAVITA VITAMIN D VITAMINS Drops - 1 Bottle 10.000UI/ML 10ML Class: A96
Oral solution  -1 Bottle 25.000UI/ML 2,5ML Class: A96
Oral solution  -2 Bottles 25.000UI/ML 2,5ML Class: A96
Oral solution - 1 Bottle 50.000UI/ML 2,5ML  Class: A96
Oral solution - 2 Bottle 50.000UI/ML 2,5ML  Class: A96

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.


Pharmacovigilance: what does it mean to monitor drugs?

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1 - Fax 02-516555.249

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl


Copyright 2024 Istituto Lusofarmaco D'Italia S.p.A.